Treating Skin Diseases with New Chemical That Triggers Immune Response with Paula Brown Stafford Novan TRANSCRIPT
Download PDFOct 17, 2022
Paula Brown Stafford is the President, CEO, and Chairman of Novan, which is focused on the research, development, and commercialization of therapies for skin diseases using a novel chemical entity. The first target indication is molluscum contagiosum, a highly contagious viral skin infection caused by molluscipoxvirus...
Oct 17, 2022
Paula Brown Stafford is the President, CEO, and Chairman of Novan, which is focused on the research, development, and commercialization of therapies for skin diseases using a novel chemical entity. The first target indication is molluscum contagiosum, a highly contagious viral skin infection caused by molluscipoxvirus...
Bringing Online Dermatology Services to a Global Audience with Dr. Alice Martin Dermanostic TRANSCRIPT
Download PDFJun 21, 2022
Dr. Alice Martin is the Co-Founder of Dermanostic, the largest teledermatology resource in Europe. Their vision is to give access to a dermatologist to everyone worldwide with a rapid diagnosis and suggested therapy, including prescriptions. While many skin conditions are not life-threatening and are often seen as...
Jun 21, 2022
Dr. Alice Martin is the Co-Founder of Dermanostic, the largest teledermatology resource in Europe. Their vision is to give access to a dermatologist to everyone worldwide with a rapid diagnosis and suggested therapy, including prescriptions. While many skin conditions are not life-threatening and are often seen as...
Accurately Addressing Needs of All Patients with Inflammation and Immunology Diseases with Mike Gladstone Pfizer TRANSCRIPT
Download PDFNov 9, 2021
Mike Gladstone is the Global President of Inflammation & Immunology at Pfizer. We talk about conditions such as rheumatoid arthritis, irritable bowel syndrome (IBS), and atopic dermatitis (AD) and how minority patients with these conditions are often misdiagnosed.
Mike explains, "Well, it turns out that a lot of these...